参考文献 [1] Endo A., et al. ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium. Journal of Antibiotics (Tokyo) 29 (12): 1346-1348(1976). [2] Endo A., et al. The discovery and development of HMG-CoA reductase inhibitors. J. Lipid Res. 33: 1569-1582 (1992). [3] Fouty BW, et al. Mevastatin Can Cause G1 Arrest and Induce Apoptosis in Pulmonary Artery Smooth Muscle Cells Through a p27Kip1-Independent Pathway. Circulation Research 92: 501- 509 (2003). [4] Nishida S, et al. Mevastatin induces apoptosis in HL60 cells dependently on decrease in phosphorylated ERK. Molecular and Cellular Biochemistry 269(1): 109-114 (2005). [5] Glynn SA, et al. The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells. BMC Cancer 8 (2008). [6] KS Ahn, et al. Reversal of chemoresistance and enhancement of apoptosis by statins through down-regulation of the NF-κB pathway. Biochemical Pharmacology 75: 907-913 (2008). [7] Wachtershauser A, et al. HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2. Carcinogenesis 22(7): 1061-1067 (2001). [8] Amin-Hanjani S, et al. Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke 32: 980-986 (2001).